Case Reports in Oncology · 2015 · 11 citations · 9 references
MedicineNeurologyOncologyChemotherapyNeoplasiaNeuro-oncologyLung CancerMalignant NeoplasmsAutoimmune Paraneoplastic SyndromesGuillain-barré Syndrome PathogenesisParaneoplastic Neurologic SyndromesParaneoplastic Neurological SyndromesParaneoplastic Neuropathy
Guillain-Barré syndrome (GBS) is defined as an acute, autoimmune polyradiculoneuropathy. It is a rare disease that occurs at a rate of 1.11 cases per 100,000 person-years. However, once infected, up to 20%percnt; of patients develop severe disability, and approximately 5%percnt; die. There have been reports of GBS in different cancers. Among them, there are 6 previous reports of GBS in small cell lung cancer. Here, we report a case of a 52-year-old man who was diagnosed with GBS in the setting of small cell lung cancer with chemotherapy.
9
Preceding infections, immune factors, and outcome in Guillain–Barre syndrome
Robert D. M. Hadden, Helge Karch, Hans‐Peter Hartung et al. · Neurology · 2001 · 375 citations
Medicine, Immunology, Neurology +14
Persistent neuropathy after treatment with cisplatin and oxaliplatin
E. E. M. Brouwers, Alwin D. R. Huitema, Willem Boogerd et al. · Acta Oncologica · 2009 · 94 citations · Full text